Jump to content

Second Pfizer/BioNTech bivalent COVID-19 booster vaccine approved by UK medicines regulator


Recommended Posts

Posted

Screenshot_10.jpg.f4d1527d58ddec5fb639ef470df7f14d.jpg

 

This adapted COVID-19 vaccine targets both the original virus and the Omicron BA.4 and BA.5 sub-variants

 

Approval has today [Nov. 9] been granted by the Medicines and Healthcare products Regulatory Agency (MHRA) for a Pfizer/BioNTech ‘bivalent’ Covid vaccine that targets both the Original strain of SARS-CoV-2 and the Omicron BA.4 and BA.5 sub-variants.

 

The updated booster vaccine is the second bivalent vaccine from Pfizer/BioNTech to receive MHRA approval, after it was found to meet the UK regulator’s standards of safety, quality and effectiveness.

 

The vaccine has been approved for use as a booster dose in individuals aged 12 years and above.

 

https://www.gov.uk/government/news/second-pfizerbiontech-bivalent-covid-19-booster-vaccine-approved-by-uk-medicines-regulator

 

Moderator's note: the prior, original version of the Pfizer bivalent COVID vaccine approved in the UK targeted earlier Omicron variants before BA.4 and BA.5.

 

https://uk.news.yahoo.com/pfizer-biontech-covid-19-booster-114312142.html

 

 

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Recently Browsing   0 members

    • No registered users viewing this page.



×
×
  • Create New...